Tom Avril

A team led by University of Pennsylvania scientists has discovered three genetic variants that offer the first strong clues as to why glaucoma disproportionately affects Black people.

Michael J. Mitchell is developing lipid nanoparticles to deliver therapy to specific organs such as the lungs and brain.

A team led by University of Pennsylvania scientists has discovered three genetic variants that offer the first strong clues as to why glaucoma disproportionately affects Black people.

A team led by University of Pennsylvania scientists has discovered three genetic variants that offer the first strong clues as to why glaucoma disproportionately affects Black people. (Dreamstime/TNS)

PHILADELPHIA -- Messenger RNA became a household term when it was used as the backbone of the first COVID-19 vaccines, especially after the Nobel Prize was awarded to two mRNA

April 3, 2024 This article has been reviewed according to Science X's editorial process and policies Editors have highlighted the following attributes while ensuring the content's credibility:

PHILADELPHIA — Messenger RNA became a household term when it was used as the backbone of the first COVID-19 vaccines, especially after the Nobel Prize was awarded to two mRNA

especially after the Nobel Prize was awarded to two mRNA pioneers at the University of Pennsylvania.